(Reuters) -Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe Holding for $256 million through a ...

Regeneron Pharmaceuticals said it will acquire substantially all of 23andMe’s assets for $256 million after coming out on top ...

File a claim with the court demanding data deletion and withdrawal of consent for data retention or resale. Mention privacy ...

Regeneron Commits to Comply with Company’s Privacy Policy and All Applicable Law; No Changes to 23andMe’s Privacy Policy or ...

Regeneron is acquiring 23andMe through a court-supervised sale, following 23andMe's bankruptcy filing and recent struggles.

We've got all the details about who's eligible for the massive 23andMe data breach settlement and how to make a claim -- plus, who might be able to get as much as $10,000.

Hey New Jerseyands, claims are now open for 23andMe's settlement over a data breach — and payouts may be as high as $10,000.

As part of its bankruptcy proceeding, 23andMe is asking those impacted by the 2023 'DNA Relatives' hack to submit a claim by ...

Genetic testing firm 23andMe must pay customers after personal information was exposed in a cybersecurity incident, if they ...

Me, the Bay Area genetic testing company that once soared in popularity but filed for bankruptcy this year, is warning that ...

According to TechCrunch, nearly 7 million users had their sensitive personal information compromised during the data breach.

Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe Holding for $256 million through a bankruptcy ...